These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24435983)

  • 1. Comment on Williams NH, et al.: a systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica (Eur Spine J, 2013;22(9):1921-35).
    Wang J; Li GT; Sun HT
    Eur Spine J; 2014 Apr; 23(4):938. PubMed ID: 24435983
    [No Abstract]   [Full Text] [Related]  

  • 2. Answer to the Letter to the Editor of Gui-Tao Li et al. concerning: "A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica" by Williams NH, Lewis R, Din NU, Matar HE, Fitzsimmons D, Phillips CJ, Sutton A, Burton K, Hendry M, Nafees S, Wilkinson C (2013) Eur Spine J; 22:1921-1935.
    Williams NH; Lewis R
    Eur Spine J; 2014 Apr; 23(4):939. PubMed ID: 24435985
    [No Abstract]   [Full Text] [Related]  

  • 3. A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica.
    Williams NH; Lewis R; Din NU; Matar HE; Fitzsimmons D; Phillips CJ; Sutton A; Burton K; Hendry M; Nafees S; Wilkinson C
    Eur Spine J; 2013 Sep; 22(9):1921-35. PubMed ID: 23529742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of tumor necrosis factor-alpha blockade for severe sciatica?].
    Genevay S; Guerne PA; Gabay C
    Rev Med Suisse Romande; 2004 Sep; 124(9):543-5. PubMed ID: 15552747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.
    Neovius M; Askling J
    Ann Rheum Dis; 2014 Jun; 73(6):e32. PubMed ID: 24638970
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study.
    Ozmen I; Erbil AH; Koc E; Tunca M
    J Dermatol; 2013 Sep; 40(9):755-6. PubMed ID: 23834032
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of spondyloarthritides with anti-TNFalpha biologic agents.
    Braun J
    Reumatismo; 2006; 58 Spec No.1():71-2. PubMed ID: 23631067
    [No Abstract]   [Full Text] [Related]  

  • 8. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis.
    Capo A; Di Nicola M; Auriemma M; Piaserico S; Cuccurullo C; Santilli F; Davi G; Amerio P
    Eur J Dermatol; 2014; 24(1):133-5. PubMed ID: 24589526
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register).
    Iannone F; Ferraccioli G; Gremese E; Lapadula G;
    Ann Rheum Dis; 2014 Jun; 73(6):e31. PubMed ID: 24368512
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancolitis during etanercept treatment of rheumatoid arthritis relapsing on the administration of further two TNF-alpha inhibitors.
    Actis GC; Lagget M; Pellicano R; Rosina F
    Int J Colorectal Dis; 2012 Apr; 27(4):547-8. PubMed ID: 21656142
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 13. Ankylosing spondylitis refractory to tumor necrosis factor blockade responds to tocilizumab.
    Cohen JD; Ferreira R; Jorgensen C
    J Rheumatol; 2011 Jul; 38(7):1527. PubMed ID: 21724733
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab in juvenile rheumatoid arthritis.
    Taddio A; Marchetti F
    N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.
    Paul S; Keat A
    Rheumatology (Oxford); 2005 Jan; 44(1):17-23. PubMed ID: 15328421
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging use of TNF-alpha inhibitors in orbital inflammatory disease.
    Kapadia MK; Rubin PA
    Int Ophthalmol Clin; 2006; 46(2):165-81. PubMed ID: 16770161
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systematic review: safety and efficacy of anti-TNF in elderly patients].
    Busquets N; Carmona L; Surís X
    Reumatol Clin; 2011; 7(2):104-12. PubMed ID: 21794793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
    Alsharqi A; Parslew R; Dever B; Arslanian V
    Australas J Dermatol; 2012 May; 53(2):e45-7. PubMed ID: 22571585
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists.
    Vujic I; Richter L; Bartsch K; Monshi B; Rappersberger K
    Eur J Dermatol; 2013; 23(6):895-6. PubMed ID: 24192269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.